BioSeed® 2017

OBN, UK and Eurasanté, France, are delighted to announce the launch of BioSeed®, a joint venture event devised to provide a unique platform for early-stage Life Sciences companies, Technology Transfer Offices (TTO) and Universities throughout Europe seeking equity investment from Angels, High-Net-Worth individuals, specialist Crowd-Funders, and PE / VC funders genuinely interested in Seed and Series ‘A’ funding.

BioSeed® is a one-day event in London on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.


BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties observing a lack of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.


Find more information here!

Event Details


Tuesday, November 14, 2017 (08:00 h - 18:30 h)


1 More London Riverside, London SE1 2AF


Prices for:
- Companies
- Investors
- TTO's & Universities




2017-11-14 08:00:00 2017-11-14 18:30:00 Europe/Brussels BioSeed® 2017 1 More London Riverside, London SE1 2AF <p><a href="" target="_blank">OBN</a><br /><a href="" target="_blank">Eurasanté</a></p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Co-General Manager

Alternate Text

Willem Dhooge

Co-General Manager

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?